The importance of hyperhomocysteinemia as a risk factor for diseases: An overview

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 8, 2001, Pages 666-674

  Herrmann, W ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Cardiovascular disease; Elderly subjects; Hyperhemocysteinemia; Methylmalonic acid; Renal disease; Vegetarians; Vitamin deficiency

Indexed keywords

CELL ADHESION MOLECULE; CYANOCOBALAMIN; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN; METHYLMALONIC ACID; REACTIVE OXYGEN METABOLITE;

AGING; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; FOAM CELL; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; KIDNEY DISEASE; NEURAL TUBE DEFECT; OBESITY; PATHOGENESIS; POSTMENOPAUSE; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

DIET, VEGETARIAN; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY DISEASES; MALE; METHYLATION; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PREGNANCY; RISK FACTORS; VASCULAR DISEASES; VITAMIN B 12 DEFICIENCY;

EID: 0034833989     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.110     Document Type: Article

References (83)

1. Homocysteine metabolism
2. The metabolism of homocysteine: Pathways and regulation
3. S-Adenosylmethionine and methylation
4. Disorders of transsulfuration
5. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
6. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
7. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia
8. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
9. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways
10. Glycine N-methyltransferase is a folate binding protein of rat liver cytosol
11. Total homocysteine in plasma or serum: Methods and clinical applications
12. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: Methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture
13. The role of homocysteine in end stage renal disease
14. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure
15. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
16. Vitamin-B-mangel im Alter
17. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people
18. Concentrations of total homocysteine in plasma in chronic renal failure
19. Vitamin B-12 deficiency in the elderly: Current dilemmas
20. High prevalence of cobalamin deficiency in the elderly
21. Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease
22. Vitamin B-6 deficiency in rats reduces hepatic serine hydroxymethyltransferase and cystathionine beta-synthase activities and rates of in vivo protein turnover, homocysteine remethylation and transsulfuration
23. Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid
24. Homocysteine
25. Homocysteine, folate, methylation, and monoamine metabolism in depression 5
26. Abnormal amino acid metabolism in patients with early stage Alzheimer dementia
27. S-adenosylmethionine levels in psychiatric and neurological disorders: A review
28. Brain function in the elderly: Role of vitamin B12 and folate
29. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease
30. Focus on Homocysteine
31. Homocysteine as a risk factor for coronary artery disease
32. Homocysteine as a risk factor for cardiovascular disease in women
33. Homocysteine as a risk factor for cerebrovascular disease and stroke
34. Homocysteine as a risk factor for peripheral vascular disease
35. Homocysteine and venous thrombosis
36. Focus on homocysteine
37. Plasma homocysteine levels and mortality in patients with coronary artery disease
38. Plasma homocyst(e)ine levels and graded risk for myocardial infarction: Findings in two populations at contrasting risk for coronary heart disease
39. Vitamins and progression of atherosclerosis in hyper-homocysteinaemia
40. Homocysteine and renal disease
41. The importance of homoysteine, cystathionine and methyl malomic acid diagnosing impaired methionine metabolism in patients with renal disease
42. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease
43. Relationship between methylmalonic acid and cobalamin in uremia
44. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss
45. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss
46. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
47. Neural tube defects, vitamins and homocysteine
48. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?
49. Hyperhomocysteinemia in high-aged subjects: Relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation
50. Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects
51. Total homocysteine, vitamin b(12), and total antioxidant status in vegetarians 1
52. Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets
53. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study
54. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons
55. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism
56. Histopathological effects of homocysteine thiolactone on epithelial and stromal tissues
57. Homocysteine metabolism and the oxidative modification of proteins and lipids
58. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels
59. Homocysteine and atherothrombosis
60. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
61. Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention
62. [Homocysteine, endothelial dysfunction and cardiovascular risk: Pathomechanisms and therapeutic options]
63. Acute hyperhomocysteinaemia and endothelial dysfunction
64. Homocysteine provokes leukocyte-endothelium interaction by down regulation of nitric oxide
65. Hyperhomocysteinaemia and endothelial dysfunction in peripheral arterial disease
66. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: Implications for vascular disease
67. Is the stimulatory effect on IL-8 expression in endothelial mediated by homocysteine oxidation products?
68. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells
69. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells
70. Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: Distinct mechanisms of thrombogenic modulation
71. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
72. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
73. Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives
74. Homocysteine: The new player in the field of coronary risk
75. Preventing coronary heart disease: B vitamins and homocysteine
76. Homocyst(e)ine: The bad aminoacid
77. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
78. Cobalamin and folate evaluation: Measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate
79. Laboratory diagnosis of vitamin B12 and folate deficiency: A guide for the primary care physician
80. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
81. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations
82. The effect of a subnormal vitamin B-6 status on homocysteine metabolism
83. Purification, characterization and differentiation-dependent expression of a perchloric acid soluble protein from rat kidney